Ordering
Available Variants100 mg
CHA.63865-100mg
Price
€48.48
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
100 mg | CHA.63865-100mg | €48.48 |
analytical standard
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C16H21NO2 · HCl |
|---|---|
| CAS Number | 318-98-9 |
| Molecular Weight | 295.80 |
| UNSPSC Code | 41116107 |
| NACRES | NA.24 |
| PubChem Substance ID | 329756000 |
| EC Number | 206-268-7 |
| Beilstein/REAXYS Number | 4164259 |
| MDL number | MFCD00012558 |
Safety Information Handling visibility
| pictograms |
GHS07
 GHS07
|
|---|---|
| signalword | Warning |
| hcodes | H302 |
| Hazard Classifications | Acute Tox. 4 Oral |
| Storage Class | 11 - Combustible Solids |
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
Technical Overview & Applications Use-case context
(±)-Propranolol hydrochloride, with a CAS number of 3506-09-0, is a non-selective beta-adrenergic receptor blocker commonly used in the treatment of various cardiovascular conditions, including hypertension, angina, and arrhythmias. Its mechanism of action involves the competitive inhibition of beta-1 and beta-2 adrenergic receptors, resulting in decreased heart rate, contractility, and cardiac output. As a hydrochloride salt, it exhibits improved solubility and bioavailability, allowing for effective oral administration. The racemic mixture of propranolol, comprising equal parts of the R- and S-enantiomers, contributes to its therapeutic efficacy and pharmacokinetic profile. With its well-established safety and efficacy, (±)-propranolol hydrochloride remains a widely prescribed medication in the management of cardiovascular diseases, and its properties continue to be the subject of ongoing research and clinical studies. Its chemical and pharmacological characteristics make it a valuable therapeutic agent.
